Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has approved Watson Laboratories' Levonorgestrel and Ethinyl Estradiol Tablets, USP, 0.09mg/0.02mg.
Subscribe to our email newsletter
Watson‘s Levonorgestrel and Ethinyl Estradiol Tablets, USP, 0.09mg/0.02mg are the generic version of Lybrel Tablets of Pfizer.
Lybrel is indicated for the prevention of pregnancy in women who choose to use oral contraceptives as a method of contraception.
Lybrel is a progesterone and estrogen combination birth control pill which works by preventing ovulation, thickening the mucus in the cervix and changing the lining of the uterus.